Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Ferritin and vitamin B12 deficiencies are common causes of hair loss in women aged 18-45.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

PCOS may increase the risk of certain cancers.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Premature birth increases the risk of striae distensae.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.